[3H]N-[1-(2-thienyl)cyclohexyl]-3,4-piperidine ([3H]TCP) binding in human frontal cortex: decreases in Alzheimer-type dementia.

Ninomiya, H; Fukunaga, R; Taniguchi, T; Fujiwara, M; Shimohama, S; Kameyama, M

Ninomiya, H; Fukunaga, R; Taniguchi, T; Fujiwara, M; Shimohama, S; Kameyama, M.

Affiliation

Ninomiya H; Department of Neurology, Faculty of Medicine, Kyoto University, Japan.

J Neurochem ; 54(2): 526-32, 1990 Feb.

Article in En | MEDLINE | ID: mdl-1967631

Subject(s)

Alzheimer Disease/metabolism; Frontal Lobe/metabolism; Phencyclidine/analogs & derivatives; Aspartic Acid/analogs & derivatives; Aspartic Acid/pharmacology; Binding Sites; Glutamates/pharmacology; Glutamic Acid; Humans; Membranes/metabolism; N-Methylaspartate; Phencyclidine/metabolism; Reference Values

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Phencyclidine / Alzheimer Disease / Frontal Lobe Language: En Journal: J Neurochem Year: 1990 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Phencyclidine / Alzheimer Disease / Frontal Lobe Language: En Journal: J Neurochem Year: 1990 Type: Article Affiliation country: Japan